Business
Odyssey Group International Announces Formation of Sports Advisory Board to Enhance Awareness of Traumatic Brain Injuries and Concussions
Odyssey Group International Announces Formation of Sports Advisory Board to Enhance Awareness of Traumatic Brain Injuries and Concussions.
About this update from Odyssey Health Inc.
[{"type":"text","content":"\n IRVINE, Calif., March 17, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the \"Company\" or \"Odyssey\"), a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to announce the formation of a Sports Advisory Board (SAB) to increase awareness regarding the unmet medical need for a treatment for brain injuries including concussion. The Company is in the pre-clinical phase of development of a drug compound (PRV-002) and is preparing for its first human clinical trial. The inaugural members of the SAB include notable professional athletes who have a passion to advance treatments for brain injuries: Kurt Warner – NFL Hall of Fame, NFL MVP, Super Bowl MVP, Super Bowl ChampionBrett Favre – NFL Hall of Fame Quarterback, Super Bowl Champion, 3x consecutive MVPMark Rypien – 2x Super Bowl Champion, 1st Canadian quarterback to start in the NFLDavid Ross – Current Manager of the Chicago Cubs, 2x World Series Champion catcherSteve “Mooch” Mariucci – Head coach San Francisco 49er’s from 1997-2002 and Detroit Lions from 2003-2005, current member of the NFL’s Player Safety Advisory Committee. The SAB will support Odyssey’s outreach efforts to enhance public awareness of traumatic brain injuries and concussion as well as the need for an FDA approved therapy. Michael Redmond, CEO of Odyssey said, “We are pleased to announce the formation of our Sports Advisory Board during Brain Injury Awareness month. Each of these new members have been directly affected by traumatic brain injury and have first-hand experience of its effects on health and quality of life. Concussion is a major health issue not only in sports but also in the military and in everyday life. Our sports advisory board will play an integral role in enhancing the public’s awareness and understanding of the impacts of this common condition for which there is currently no FDA-approved drug treatment. We believe that if we successfully develop and commercialize PRV-002, we will be able to significantly improve outcomes for concussion patients.” About Odyssey Group International, Inc.Odyssey Group International, Inc. (OTCQB:ODYY) is a technology and asset acquisition company with a focus in the area of life saving medical ...